Anthony Girand
Also known as Tony Girand, Anthony Girand is a JD/MBA attorney, AI founder, SaaS operator, startup builder, and business development executive working across law, finance, healthcare, compliance, fintech, and regulated markets.
Featured In & Associated With
Anthony Girand at a Glance
Also known as Tony Girand, a JD/MBA attorney, AI founder, SaaS operator, and business development executive working across law, finance, healthcare, and regulated markets.
Current Work
Three decades across law, Wall Street, SaaS, and AI — connected by a single mission: building systems that create measurable outcomes.
CEO, HedgeNova
Building the future of algorithmic trading for individual investors. Democratizing access to institutional-grade quantitative strategies.
Attorney & MoCRA Compliance
JD from University of Baltimore, MBA from Duke Fuqua. Startup law, regulatory compliance, and AI-driven MoCRA solutions for cosmetics brands.
AI Founder & SaaS Executive
CRO-level revenue leadership across enterprise SaaS, paired with hands-on work building AI-driven, agentic compliance and trading systems.
Wall Street & Enterprise SaaS
VP at Morgan Stanley & Credit Suisse advising UHNW clients. Drove ARR from $8M→$18M at Scoro; $5M→$11M at Decile. CRO-level operating experience.
Co-Founder, VoyagerMed
Co-founded and led healthcare access startup connecting patients with leading U.S. physicians. Acquired.
AI-Driven Compliance Systems
Applying AI to MoCRA compliance workflows for cosmetics and personal care brands — registration tracking, safety substantiation, and reporting.
Career Highlights
Press and Public References
Where to find Anthony Girand — also known as Tony Girand — across the web.
Latest Writing
View all articlesThe Legal and Financial Collision of Agentic AI: Why 88% of Enterprise Deployments Are Walking Into a Liability Trap
As enterprise AI agent adoption skyrockets, companies are blindly walking into a legal and financial minefield. Here is why the legal definition of 'agency' will dictate the next era of SaaS.
Healthcare InnovationThe FDA Just Killed the 'SaaS Wrapper' in Healthcare AI: Why Competency-Based Regulation Changes Everything
The FDA's recent proposal to evaluate GenAI medical devices through a 'competency-based approach' signals the end of the move-fast-and-break-things era in healthcare AI.
Startups & GTMThe Death of Per-Seat SaaS: Why Agentic AI is Forcing a Financial and Legal Reckoning in GTM
Enterprise AI adoption has crossed a tipping point in 2026, shifting SaaS from per-seat software to outcome-based autonomous agents. Here is the financial and legal reality for founders navigating this transition.
Contact Anthony Girand
Legal, advisory, AI/SaaS, investment, or media inquiries welcome.
Contact Anthony Girand